NextPlat (NXPL) Current Deferred Revenue (2014 - 2025)
NextPlat's (NXPL) quarterly Current Deferred Revenue came in at $200000.0 in Q4 2025, up 100.0% year-over-year from $100000.0 in Q4 2024, and down 17.7% quarter-over-quarter from $243000.0 in Q3 2025.
Powered by 
Analysis
NextPlat (NXPL) Current Deferred Revenue (2014 - 2025) Analysis & Trends
NextPlat (NXPL) has reported Current Deferred Revenue for 12 consecutive years, with $200000.0 the latest figure, recorded in Q4 2025.
- On a quarterly basis, Current Deferred Revenue rose 100.0% year-over-year to $200000.0 in Q4 2025; TTM through Dec 2025 was $200000.0, a 100.0% increase from a year earlier, with the FY2025 full-year figure at $200000.0, up 100.0% from the prior year.
- Current Deferred Revenue was $200000.0 for Q4 2025 at NextPlat, down from $243000.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $303000.0 in Q2 2025 and troughed at $27110.0 in Q2 2022.
- A 5-year average of $90707.4 and a median of $41586.5 in 2021 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue slumped 34.16% in 2022 and jumped 311.76% in 2024, its largest moves.
- Over 5 years, Current Deferred Revenue stood at $36765.0 in 2021, then slipped by 2.08% to $36000.0 in 2022, then grew by 16.67% to $42000.0 in 2023, then soared by 138.1% to $100000.0 in 2024, then soared by 100.0% to $200000.0 in 2025.
- The last three Current Deferred Revenue figures came in at $200000.0 (Q4 2025), $243000.0 (Q3 2025), and $303000.0 (Q2 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn |
| 10 | NextPlat | 24.77 Mn | 12.93 Mn | 4.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 200,000.00 |
| Sep 30, 2025 | 243,000.00 |
| Jun 30, 2025 | 303,000.00 |
| Mar 31, 2025 | 139,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 104,000.00 |
| Jun 30, 2024 | 142,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 42,000.00 |
| Sep 30, 2023 | 29,223.00 |
| Jun 30, 2023 | 59,000.00 |
| Mar 31, 2023 | 34,000.00 |
| Dec 31, 2022 | 36,000.00 |
| Sep 30, 2022 | 35,009.00 |
| Jun 30, 2022 | 27,110.00 |
| Mar 31, 2022 | 30,364.00 |
| Dec 31, 2021 | 36,765.00 |
| Sep 30, 2021 | 40,956.00 |
| Jun 30, 2021 | 41,173.00 |
| Mar 31, 2021 | 31,547.00 |